This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

UBS analyst Leonardo Olmos downgraded the rating for Globant S.A. GLOB from Buy to Neutral, while raised the price target from $225 to $235. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
Citigroup analyst Thomas Singlehurst downgraded Stride, Inc. LRN from Buy to Neutral, but increased the price target from $77 to $90. Stride shares gained 1.5% to close at $83.77 on Monday. See how other analysts view this stock.
JP Morgan analyst Tien-Tsin Huang downgraded the rating for AvidXchange Holdings, Inc. AVDX from Overweight to Neutral and lowered the price target from $11 to $9. AvidXchange shares gained 1.4% to close at $8.24 on Monday. See how other analysts view this stock.
JMP Securities analyst Nicholas Jones downgraded PropertyGuru Group Limited PGRU from Market Outperform to Market Perform. PropertyGuru shares settled at $6.55 on Monday. See how other analysts view this stock.
Benchmark analyst Robert Wasserman downgraded the rating for AbCellera Biologics Inc. ABCL from Buy to Hold. AbCellera Biologics shares gained 3.8% to close at $2.71 on Monday. See how other analysts view this stock. See how other analysts view this stock.